🇺🇸
United States · US · US:71335-1827_99522782-da02-4402-b98a-40b831694bf8
Levothyroxine sodium
In shortageOrange BookUNIISPLATC H03AA01
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerBryant Ranch Prepack
CountryUS (United States)
ATC codeH03AA01
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 6
- ndc11713351827130 TABLET in 1 BOTTLE (71335-1827-1)
- ndc117133518272100 TABLET in 1 BOTTLE (71335-1827-2)
- ndc11713351827360 TABLET in 1 BOTTLE (71335-1827-3)
- ndc11713351827490 TABLET in 1 BOTTLE (71335-1827-4)
- ndc11713351827528 TABLET in 1 BOTTLE (71335-1827-5)
- ndc11713351827610 TABLET in 1 BOTTLE (71335-1827-6)
Annotations
UNII (FDA Substance ID)
9J765S329G
LEVOTHYROXINE SODIUM
RxCUI 40144
Orange Book
A212399
AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Levothyroxine Sodium Tablet
Raw payload (JSON)
{
"unii": {
"unii": "9J765S329G",
"rxcui": "40144",
"inchikey": "JMHCCAYJTTWMCX-QWPJCUCISA-M",
"display_name": "LEVOTHYROXINE SODIUM",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"5852d874-1ebc-49ff-b6c2-1dd513fca784": {
"match": "brand_token",
"title": "LEVOTHYROXINE SODIUM TABLET [BRYANT RANCH PREPACK]",
"spl_version": "102",
"published_date": "2026-05-28"
}
},
"productid": "71335-1827_99522782-da02-4402-b98a-40b831694bf8",
"productndc": "71335-1827",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "212399",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "001",
"approval_date": "Oct 19, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "002",
"approval_date": "Oct 19, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "003",
"approval_date": "Oct 19, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "004",
"approval_date": "Oct 19, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "005",
"approval_date": "Oct 19, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "006",
"approval_date": "Oct 19, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "007",
"approval_date": "Oct 19, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "008",
"approval_date": "Oct 19, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "009",
"approval_date": "Oct 19, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "010",
"approval_date": "Oct 19, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "011",
"approval_date": "Oct 19, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "012",
"approval_date": "Oct 19, 2020"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "LEVOTHYROXINE SODIUM",
"shortage_reason": "Levothyroxine Sodium Tablet",
"shortage_status": "current",
"proprietary_name": "Levothyroxine sodium",
"active_ingred_unit": "ug/1",
"application_number": "ANDA212399",
"marketing_category": "ANDA",
"nonproprietary_name": "Levothyroxine Sodium",
"start_marketing_date": "20201125",
"active_numerator_strength": "75"
}Related drugs
Other records sharing ATC code H03AA01.
Access this data programmatically
Query Levothyroxine sodium and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.